Alzheimer's disease APOE testing is inappropriate in asymptomatic patients, NIA/AA panel says.
This article was originally published in The Gray Sheet
Executive Summary
ALZHEIMER'S DISEASE APOE GENETIC TESTING UNWARRANTED IN ASYMPTOMATIC patients, according to a National Institute on Aging/ Alzheimer's Association Working Group consensus statement published April 20 in The Lancet. "The usefulness of APOE [apolipoprotein E] genotyping for predicting risk of AD in asymptomatic individuals has not been established in longitudinal population studies and as such is not recommended by the working group at this time," the statement says.